Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Newcomb

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Neurosurgery|September 1, 1994
Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumorsF F Lang, D C Miller, M Koslow, et al.
Journal of Cellular Physiology|December 1, 1975
Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisionsJ R Wrathall, E W Newcomb, R Balint, et al.
Molecular Carcinogenesis|November 1, 1995
Alterations of multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and DBM (13q14)) in B-cell chronic lymphocytic leukemiaE W Newcomb, L S Rao, S S Giknavorian, et al.
Leukemia|March 1, 1996
A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cellsE Davis, K Krishnan, H Yan, et al.
Cancer Research|May 15, 1995
Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivationE W Newcomb, A Thomas, A Selkirk, et al.
Oncogene|March 1, 1994
High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomasF F Lang, D C Miller, S Pisharody, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1975
Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cellsJ K Christman, S Silagi, E W Newcomb, et al.
Journal of the American College of Cardiology|November 1, 1984
Atherosclerotic aneurysm of the left main coronary arteryE W Newcomb, D J Youngman, N A Burton, et al.
Environmental Health Perspectives|June 1, 1991
ras activation in human tumors and in animal model systemsM Corominas, S R Sloan, J Leon, et al.
Journal of Cellular Physiology|May 1, 1978
Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cellsD Kyner, J Christman, G Acs, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Neurosurgery|September 1, 1994
Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumorsF F Lang, D C Miller, M Koslow, et al.
Journal of Cellular Physiology|December 1, 1975
Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisionsJ R Wrathall, E W Newcomb, R Balint, et al.
Molecular Carcinogenesis|November 1, 1995
Alterations of multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and DBM (13q14)) in B-cell chronic lymphocytic leukemiaE W Newcomb, L S Rao, S S Giknavorian, et al.
Leukemia|March 1, 1996
A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cellsE Davis, K Krishnan, H Yan, et al.
Cancer Research|May 15, 1995
Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivationE W Newcomb, A Thomas, A Selkirk, et al.
Oncogene|March 1, 1994
High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomasF F Lang, D C Miller, S Pisharody, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1975
Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cellsJ K Christman, S Silagi, E W Newcomb, et al.
Journal of the American College of Cardiology|November 1, 1984
Atherosclerotic aneurysm of the left main coronary arteryE W Newcomb, D J Youngman, N A Burton, et al.
Environmental Health Perspectives|June 1, 1991
ras activation in human tumors and in animal model systemsM Corominas, S R Sloan, J Leon, et al.
Journal of Cellular Physiology|May 1, 1978
Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cellsD Kyner, J Christman, G Acs, et al.
Pageof 5